Organogenesis Holdings Inc (ORGO)
Healthcare
Drug Manufacturers - Specialty & Generic
2.40 $
-3.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Organogenesis Holdings Inc (ORGO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 44.6% of the shares are freely tradable; institutional investors hold 49.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
49.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
47.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
44.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
15.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
129Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Morgan Stanley - Brokerage Accounts | 9.03 | 11,616,795 | -0.2 | 03/31/2026 |
| Soleus Capital Management, L.P. | 7.84 | 10,085,951 | +1.0 | 03/31/2026 |
| Vanguard Group Inc | 3.85 | 4,958,876 | -1.5 | 12/31/2025 |
| BlackRock Inc | 3.81 | 4,899,751 | +2.9 | 03/31/2026 |
| First Light Asset Management, LLC | 2.72 | 3,498,533 | -9.4 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.25 | 2,900,816 | +0.0 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 2.25 | 2,891,006 | +5.9 | 03/31/2026 |
| D. E. Shaw & Co LP | 1.79 | 2,297,974 | +15.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Xtrackers S&P 500 Swap ETF 1C | 2.51 | 3,224,113 | -0.7 | 12/31/2025 |
| Vanguard Total Stock Mkt Idx Inv | 1.55 | 1,991,446 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.